17 August 2018
The Ministry of Industry and Trade of the Russian Federation prepared a draft decree of the Government of the Russian Federation “On the approval of the Strategy for the Development of the Medical Industry of the Russian Federation for the Period up to 2030”.
According to the explanatory note to the document, the strategic goals of the Russian Medical Industry development until 2030 are as follows:
To achieve these goals, the following objectives will be accomplished:
The strategy will be implemented in two phases. The implementation of the first stage is aimed at the formation of a regulatory legal framework that provides regulations for the industry and implementation of financial and non-financial support measures.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024